Arsenic Trioxide Stabilizes Accumulations of Adeno-Associated Virus Virions at the Perinuclear Region, Increasing Transduction In Vitro and In Vivo
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Interactions with cellular stress pathways are central to the life cycle of many latent viruses. Here, we utilize adeno-associated virus (AAV) as a model to study these interactions, as previous studies have demonstrated that cellular stressors frequently increase transduction of recombinant AAV (rAAV) vectors and may even substitute for helper virus functions. Since several chemotherapeutic drugs are known to increase rAAV transduction, we investigated the effect of arsenic trioxide (As 2 O 3 ), an FDA-approved chemotherapeutic agent with known effects on several other virus life cycles, on the transduction of rAAV. In vitro , As 2 O 3 caused a dose-dependent increase in rAAV2 transduction over a broad range of cell lines from various cell types and species (e.g., HEK-293, HeLa, HFF hTERT, C-12, and Cos-1). Mechanistically, As 2 O 3 treatment acted to prevent loss of virions from the perinuclear region, which correlated with increased cellular vector genome retention, and was distinguishable from proteasome inhibition. To extend our investigation of the cellular mechanism, we inhibited reactive oxygen species formation and determined that the As 2 O 3 -mediated increase in rAAV2 transduction was dependent upon production of reactive oxygen species. To further validate our in vitro data, we tested the effect of As 2 O 3 on rAAV transduction in vivo and determined that treatment initiated transgene expression as early as 2 days posttransduction and increased reporter expression by up to 10-fold. Moreover, the transduction of several other serotypes of rAAV was also enhanced in vivo , suggesting that As 2 O 3 affects a pathway used by several AAV serotypes. In summary, our data support a model wherein As 2 O 3 increases rAAV transduction both in vitro and in vivo and maintains perinuclear accumulations of capsids, facilitating productive nuclear trafficking.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Arsenic trioxide (As (2)O (3)), one oxidizing agent and FDA-approved chemotherapeutic drug, has been shown to stabilize AAV by reducing proteasome-mediated degradation (71).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [71]
In the citing paper
“Intraperitoneal administration of arsenic trioxide enhanced transduction and transgene expression after intravenous AAV delivery in mice (71).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [71]
In the citing paper
“Intraperitoneal ATO 5μg/g/day from day -2 to 2 showed 3.9-fold increase in luciferase assay 12 days after rAAV8 retro-orbital injection, with dose-dependent increase of intracellular reactive oxygen species that inhibit vector degradation pathways (59).”
From Immunomodulation in Administration of RAAV: Preclinical and Clinical Adjuvant Pharmacotherapies (2021) · cites this paper as [59]
Citations
Cites
1 retracted
Jayandharan, G. R., Aslanidi, G., Martino, A. T., Jahn, S. C., Perrin, G. Q., Herzog, R. W., & Srivastava, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012753108 · Cited by 72
RetractedManno, C. S., Pierce, G. F., Arruda, V. R., Glader, B., Ragni, M., Rasko, J. J. E., Ozelo, M. C., Hoots, K., Blatt, P., Konkle, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1358 · Cited by 2,163 · cited 1×
“For some gene therapy applications, especially those involving systemic gene delivery, low levels of transgene expression or loss of transgene expression over time have limited the efficacy observed in clinical settings (60, 61).”
BackgroundAdenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
Nathwani, A. C., Tuddenham, E. G. D., Rangarajan, S., Rosales, C., McIntosh, J., Linch, D. C., Chowdary, P., Riddell, A., Pie, A. J., Harrington, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108046 · Cited by 1,864
Shen, Z.-X., Chen, G.-Q., Ni, J.-H., Li, X.-S., Xiong, S.-M., Qiu, Q.-Y., Zhu, J., Tang, W., Sun, G.-L., Yang, K.-Q., et al. (1997) · Blood · doi:10.1182/blood.v89.9.3354 · Cited by 1,428 · cited 1×
“To determine whether the increase in rAAV2 transduction we observed with As2O3 in vitro could be replicated in vivo, we treated mice for 5 days with a dose of 5 g/g/day As2O3, which replicates the levels of serum As2O3 observed in promyelocytic leukemia patients treated with this drug (47, 48).”
MethodMechanisms of action of arsenic trioxide.
Miller, W. H., Schipper, H. M., Lee, J. S., Singer, J. W., & Waxman, S. (2002) · PubMed · Cited by 1,096
Ferrari, F. K., Samulski, T., Shenk, T., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3227-3234.1996 · Cited by 761
Self-citationProduction and characterization of adeno-associated viral vectors
Grieger, J. C., Choi, V. W., & Samulski, R. J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.207 · Cited by 581
Self-citationMcCarty, D. M., Fu, H., Monahan, P. E., Toulson, C. E., Naik, P., & Samulski, R. J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302134 · Cited by 547
Self-citationDai, J., Weinberg, R. S., Waxman, S., & Jing, Y. (1999) · Blood · doi:10.1182/blood.v93.1.268 · Cited by 540
Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors
Bartlett, J. S., Wilcher, R., & Samulski, R. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2777-2785.2000 · Cited by 532 · cited 1×
“receptor-mediated endocytosis (4) and is trafficked through en-”
BackgroundSelf-citationLazo, G., Kantarjian, H., Estey, E., Thomas, D., O'Brien, S., & Cortes, J. (2003) · Cancer · doi:10.1002/cncr.11314 · Cited by 494
Nakai, H., Yant, S. R., Storm, T. A., Fuess, S., Meuse, L., & Kay, M. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.6969-6976.2001 · Cited by 478 · cited 1×
“can persist episomally for long time periods (1).”
BackgroundEndosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus
Duan, D., Yue, Y., Yan, Z., Yang, J., & Engelhardt, J. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8317 · Cited by 391
Kapahi, P., Takahashi, T., Natoli, G., Adams, S. R., Chen, Y., Tsien, R. Y., & Karin, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007204200 · Cited by 359
Park, W. H., Seol, J. G., Kim, E.-K., Hyun, J. M., Jung, C. W., Lee, C. R., Kim, B.-K., & Lee, Y. Y. (2000) · PubMed · Cited by 345
PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3
Jeanne, M., Lallemand-Breitenbach, V., Ferhi, O., Koken, M., Le Bras, M., Duffort, S., Peres, L., Berthier, C., Soilihi, H., Raught, B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.003 · Cited by 335
Lallemand-Breitenbach, V., Guillemin, M.-C., Janin, A., Daniel, M.-T., Degos, L., Kogan, S. C., Michael Bishop, J., & de Thé, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1043 · Cited by 305
Arsenite Induces Apoptosis via a Direct Effect on the Mitochondrial Permeability Transition Pore
Larochette, N., Decaudin, D., Jacotot, E., Brenner, C., Marzo, I., Susin, S. A., Zamzami, N., Xie, Z., Reed, J., & Kroemer, G. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4519 · Cited by 301 · cited 1×
“On a cellular level, As2O3 has many effects, including inducing reactive oxygen species (ROS) formation (28), inhibiting NF- B activation (29), degrading the promyelocytic leukemia protein (PML) (30), changing mitochondrial membrane potentials (31), inducing global changes in transcriptional patterns (32), and, at hig…”
BackgroundDouar, A.-M., Poulard, K., Stockholm, D., & Danos, O. (2001) · Journal of Virology · doi:10.1128/jvi.75.4.1824-1833.2001 · Cited by 282
Sanlioglu, S., Benson, P. K., Yang, J., Atkinson, E. M., Reynolds, T., & Engelhardt, J. F. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9184-9196.2000 · Cited by 269 · cited 1×
“These data suggest a model in which, in both As2O3-treated and untreated cells, rAAV virions enter the cell and are trafficked along microtubules to the MTOC, where they accumulate (5, 45).”
BackgroundDNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors.
Russell, D. W., Alexander, I. E., & Miller, A. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5719 · Cited by 218 · cited 1×
“As As2O3 affects these other viruses, and chemotherapeutic agents, such as proteasome inhibitors (6, 39) and topoisomerase inhibitors (18), have been demonstrated to enhance rAAV transduction, we determined whether As2O3 has an effect on initial rAAV transduction.”
BackgroundDNA amplification of adeno-associated virus as a response to cellular genotoxic stress.
Yalkinoglu, A. Ö., Heilbronn, R., Bürkle, A., Schlehofer, J. R., & Hausen, H. Z. (1988) · PubMed · Cited by 218
Spuches, A. M., Kruszyna, H. G., Rich, A. M., & Wilcox, D. E. (2005) · Inorganic Chemistry · doi:10.1021/ic048694q · Cited by 206
Role of Promyelocytic Leukemia Protein in Host Antiviral Defense
Geoffroy, M.-C., & Chelbi-Alix, M. K. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0111 · Cited by 185
Xiao, P.-J., & Samulski, R. J. (2012) · Journal of Virology · doi:10.1128/jvi.00935-12 · Cited by 163
Self-citationEnhancement of Adeno-Associated Virus Infection by Mobilizing Capsids into and Out of the Nucleolus
Johnson, J. S., & Samulski, R. J. (2009) · Journal of Virology · doi:10.1128/jvi.02309-08 · Cited by 162 · cited 9×
“Increased vector copy number is also observed with proteasome inhibition of AAV-transduced cells, which induces the nucleolar localization of rAAV2 (6); therefore, we investigated whether the effects of proteasome inhibition and As2O3 treatment on AAV2 transduction overlap.”
BackgroundResultInfluentialSelf-citationThe induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms
Zhang, W., Ohnishi, K., Shigeno, K., Fujisawa, S., Naito, K., Nakamura, S., Takeshita, K., Takeshita, A., & Ohno, R. (1998) · Leukemia · doi:10.1038/sj.leu.2401112 · Cited by 158
Xiao, X., Xiao, W., Li, J., & Samulski, R. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.941-948.1997 · Cited by 155 · cited 1×
“the only cis elements required for vector production (2), allowing”
BackgroundSelf-citationAdenovirus-Facilitated Nuclear Translocation of Adeno-Associated Virus Type 2
Xiao, W., Warrington, K. H., Hearing, P., Hughes, J., & Muzyczka, N. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11505-11517.2002 · Cited by 137 · cited 1×
“cient, including nuclear entry (7) and second-strand synthesis (8,”
BackgroundMonahan, P. E., Lothrop, C. D., Sun, J., Hirsch, M. L., Kafri, T., Kantor, B., Sarkar, R., Tillson, D. M., Elia, J. R., & Samulski, R. J. (2010) · Molecular Therapy · doi:10.1038/mt.2010.170 · Cited by 125
Self-citationOpportunities for Trisenox® (arsenic trioxide) in the treatment of myelodysplastic syndromes
List, A. F., Beran, M., DiPersio, J. F., Slack, J. L., Vey, N., Rosenfeld, C. S., & Greenberg, P. L. (2003) · Leukemia · doi:10.1038/sj.leu.2403021 · Cited by 115
Au, W.-Y., Kumana, C. R., Lee, H. K. K., Lin, S.-Y., Liu, H., Yeung, D. Y. M., Lau, J. S. M., & Kwong, Y.-L. (2011) · Blood · doi:10.1182/blood-2011-05-354530 · Cited by 101
Park, J.-W., Choi, Y.-J., Jang, M. A., Baek, S.-H., Lim, J. H., Passaniti, T., & Kwon, T. K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5416 · Cited by 97 · cited 1×
“On a cellular level, As2O3 has many effects, including inducing reactive oxygen species (ROS) formation (28), inhibiting NF- B activation (29), degrading the promyelocytic leukemia protein (PML) (30), changing mitochondrial membrane potentials (31), inducing global changes in transcriptional patterns (32), and, at hig…”
BackgroundAAVs Anatomy: Roadmap for Optimizing Vectors for Translational Success
M. Mitchell, A., C. Nicolson, S., K. Warischalk, J., & Jude Samulski, R. (2010) · Current Gene Therapy · doi:10.2174/156652310793180706 · Cited by 96
Self-citationLi, C., Diprimio, N., Bowles, D. E., Hirsch, M. L., Monahan, P. E., Asokan, A., Rabinowitz, J., Agbandje-McKenna, M., & Samulski, R. J. (2012) · Journal of Virology · doi:10.1128/jvi.00675-12 · Cited by 96 · cited 1×
“vectors has been previously described (44).”
Self-citationBulliard, Y., Narvaiza, I., Bertero, A., Peddi, S., Röhrig, U. F., Ortiz, M., Zoete, V., Castro-Díaz, N., Turelli, P., Telenti, A., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01651-10 · Cited by 84
Decision Making in Living Cells: Lessons from a Simple System
Golding, I. (2011) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-042910-155227 · Cited by 64 · cited 1×
“to the reactivation of many latent viruses, from lambda phage (13)”
BackgroundJennings, K., Miyamae, T., Traister, R., Marinov, A., Katakura, S., Sowders, D., Trapnell, B., Wilson, J. M., Gao, G., & Hirsch, R. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.10.020 · Cited by 59 · cited 1×
“As As2O3 affects these other viruses, and chemotherapeutic agents, such as proteasome inhibitors (6, 39) and topoisomerase inhibitors (18), have been demonstrated to enhance rAAV transduction, we determined whether As2O3 has an effect on initial rAAV transduction.”
BackgroundEndocytic processing of adeno-associated virus type 8 vectors for transduction of target cells
Liu, Y., Joo, K.-I., & Wang, P. (2012) · Gene Therapy · doi:10.1038/gt.2012.41 · Cited by 59 · cited 1×
“In addition, a recent report suggested that, perhaps due to differences in receptor usage, rAAV2 and rAAV8 differentially traffic through endosomal compartments and have different requirements for endosomal escape (50).”
BackgroundHong, S.-H., Yang, Z., & Privalsky, M. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.21.7172-7182.2001 · Cited by 59
The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms
張, 文. (2000) · Institutional Repositories DataBase (IRDB) · doi:10.11501/3165072 · Cited by 59
Zhong, L., Qing, K., Si, Y., Chen, L., Tan, M., & Srivastava, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310548200 · Cited by 49
Johnson, J. S., Gentzsch, M., Zhang, L., Ribeiro, C. M. P., Kantor, B., Kafri, T., Pickles, R. J., & Samulski, R. J. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002053 · Cited by 48 · cited 1×
“cellular stress, including endoplasmic reticulum stress associated with unfolded protein responses (10), treatment with chemother-”
BackgroundSelf-citationHerpes Viruses, Cytokines, and Altered Hemostasis in Vital Exhaustion
van der Ven, A., van Diest, R., Hamulyák, K., Maes, M., Bruggeman, C., & Appels, A. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000058378.50240.80 · Cited by 46
Inhibition of Hepatitis C Virus Replication by Arsenic Trioxide
Hwang, D.-R., Tsai, Y.-C., Lee, J., Huang, K., Lin, R.-K., Ho, C.-H., Chiou, J., Lin, Y., Hsu, J. T.-A., & Yeh, C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.2876-2882.2004 · Cited by 44 · cited 5×
“However, activation of EBV replication in response to As2O3 was correlated with the degradation of PML, although no direct evidence of a link was presented (59), while the induction of HCMV immediateearly gene synthesis by sodium arsenite, another trivalent arsenic compound, was suggested to be the result of heat shoc…”
BackgroundInfluentialSebastian, S., Sokolskaja, E., & Luban, J. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.2051-2054.2006 · Cited by 43
Kuroki, M., Ariumi, Y., Ikeda, M., Dansako, H., Wakita, T., & Kato, N. (2008) · Journal of Virology · doi:10.1128/jvi.01840-08 · Cited by 41 · cited 5×
“However, activation of EBV replication in response to As2O3 was correlated with the degradation of PML, although no direct evidence of a link was presented (59), while the induction of HCMV immediateearly gene synthesis by sodium arsenite, another trivalent arsenic compound, was suggested to be the result of heat shoc…”
BackgroundInfluentialKeiser, N. W., Yan, Z., Zhang, Y., Lei-Butters, D. C. M., & Engelhardt, J. F. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.044 · Cited by 40 · cited 1×
“For instance, rAAV1 and rAAV5 can traffic to the nucleus of HeLa cells more quickly than rAAV2 but have lower levels of transduction due to either poor uncoating or rapid degradation, respectively (49).”
BackgroundGu, Y., Lewis, D. F., Zhang, Y., Groome, L. J., & Wang, Y. (2006) · Hypertension in Pregnancy · doi:10.1080/10641950600912950 · Cited by 39 · cited 1×
“fication of ROS levels by DHE staining has been previously described (43).”
MethodŞanlıoğlu, S., & Engelhardt, J. F. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300967 · Cited by 37 · cited 2×
“Several studies have suggested a positive role for NF- B activation in rAAV transduction (52, 53), and several other ROS generators, such as UV light and H2O2, have been shown to increase NF- B activation, although this activation was not necessary for their effects on AAV transduction (51, 52).”
BackgroundResultAu, W., & Kwong, Y. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.07.030 · Cited by 35 · cited 6×
“Moreover, treatment of patients with As2O3 often leads to the reactivation of varicella-zoster virus (VZV) and HSV (37, 38); in fact, the risk of patients developing herpes zoster after As2O3 treatment is 26%, which is higher than the 20% risk found with severe immunosuppression after hematopoietic stem cell transplan…”
BackgroundInfluentialSides, M. D., Block, G. J., Shan, B., Esteves, K. C., Lin, Z. N., Flemington, E. K., & Lasky, J. A. (2011) · Virology · doi:10.1016/j.virol.2011.04.005 · Cited by 34 · cited 2×
“Interestingly, several lines of evidence have suggested that trivalent arsenic can induce lytic replication in alphaherpesviruses (HSV and VZV), betaherpesviruses (human cytomegalovirus [HCMV]), and gammaherpesviruses (Epstein-Barr virus [EBV]) (37, 38, 58, 59).”
BackgroundQuantitative 3D Tracing of Gene-delivery Viral Vectors in Human Cells and Animal Tissues
Xiao, P.-J., Li, C., Neumann, A., & Samulski, R. J. (2012) · Molecular Therapy · doi:10.1038/mt.2011.250 · Cited by 33
Self-citationHuang, W. C., Xie, P., Xu, M., Li, P., & Zao, G. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9167-7 · Cited by 33 · cited 1×
“(15), some may result from specific changes in the intracellular”
BackgroundPrasad, K.-M. R., Xu, Y., Yang, Z., Toufektsian, M.-C., Berr, S. S., & French, B. A. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300071 · Cited by 33
Wheeler, M. D., Kono, H., Rusyn, I., Arteel, G. E., McCarty, D. M., Samulski, R. J., & Thurman, R. G. (2000) · Hepatology · doi:10.1053/jhep.2000.19339 · Cited by 31
Self-citationGeelen, J. L. M. C., Boom, R., Klaver, G. P. M., Minnaar, R. P., Feltkamp, M. C. W., van Milligen, F. J., Sol, C. J. A., & van der Noordaa, J. (1987) · Journal of General Virology · doi:10.1099/0022-1317-68-11-2925 · Cited by 29 · cited 2×
“Interestingly, several lines of evidence have suggested that trivalent arsenic can induce lytic replication in alphaherpesviruses (HSV and VZV), betaherpesviruses (human cytomegalovirus [HCMV]), and gammaherpesviruses (Epstein-Barr virus [EBV]) (37, 38, 58, 59).”
BackgroundJu, X., Lou, S., Wang, W., Peng, J.-Q., & Tian, H. (2004) · PubMed · Cited by 27
Nouri, K., Ricotti, C. A., Bouzari, N., Chen, H., Ahn, E. R., & Ardalan, B. (2006) · PubMed · Cited by 21
Curing All Patients with Acute Promyelocytic Leukemia: Are We There Yet?
Baljevic, M., Park, J. H., Stein, E., Douer, D., Altman, J. K., & Tallman, M. S. (2011) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2011.10.002 · Cited by 20
Bortezomib-associated fatal liver failure in a haemodialysis patient with multiple myeloma
Cornelis, T., Beckers, E. A. M., Driessen, A. L. C., SANDE, F. M. V. D., & Koek, G. H. (2012) · Clinical Toxicology · doi:10.3109/15563650.2012.673624 · Cited by 19 · cited 2×
“Although bortezomib is approved for use in humans, it has serious toxic side effects, and in rare cases its use can lead to liver failure and death (17, 22).”
BackgroundArsenic modulates APOBEC3G-mediated restriction to HIV-1 infection in myeloid dendritic cells
Stalder, R., Blanchet, F. P., Mangeat, B., & Piguet, V. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310176 · Cited by 11 · cited 1×
“As2O3 causes an enhancement of HIV replication only in nonpermissive cell types in a manner that depends on the expression of TRIM5 and APOBEC3G (35, 36).”
BackgroundMurine double minute 2 as a modulator of retroviral restrictions mediated by TRIM5α
Malbec, M., Pham, Q. T., Plourde, M. B., Létourneau-Hogan, A., Nepveu-Traversy, M.-É., & Berthoux, L. (2010) · Virology · doi:10.1016/j.virol.2010.06.021 · Cited by 10
Cited by
Engineering adeno-associated virus vectors for gene therapy
Li, C., & Samulski, R. J. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0205-4 · Cited by 1,175
Self-citationEmerging issues in AAV-mediated in vivo gene therapy
Colella, P., Ronzitti, G., & Mingozzi, F. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.11.007 · Cited by 881
AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges
Kang, L., Jin, S., Wang, J., Lv, Z., Xin, C., Tan, C., Zhao, M., Wang, L., & Liu, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.067 · Cited by 131
Journey to the Center of the Cell: Tracing the Path of AAV Transduction
Dhungel, B. P., Bailey, C. G., & Rasko, J. E. J. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.09.010 · Cited by 122
Strategy to detect pre-existing immunity to AAV gene therapy
Falese, L., Sandza, K., Yates, B., Triffault, S., Gangar, S., Long, B., Tsuruda, L., Carter, B., Vettermann, C., Zoog, S. J., et al. (2017) · Gene Therapy · doi:10.1038/gt.2017.95 · Cited by 101
Metadata
- Authors
- Mitchell, A. M., Li, C., & Samulski, R. J.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2013-04-15
- Volume
- 87
- Issue
- 8
- Pages
- 4571-4583
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC3624361
- OpenAlex
- W1979549283
- Cited by
- 41
- References
- 63
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 5 · 2022: 1 · 2021: 2 · 2020: 7 · 2019: 4 · 2018: 5 · 2017: 2 · 2016: 3 · 2015: 2 · 2014: 5 · 2013: 2
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health (5u54ar056953-05, 5U54AR056953)
- University of North Carolina at Chapel Hill
- National Institute of Allergy and Infectious Diseases (R01AI072176, R01AI080726, T32AI007419)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK084033)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (5U54AR056953, U54-AR056953)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Keywords
- arsenic trioxide, adeno-associated virus, recombinant AAV vectors, viral transduction, nuclear trafficking, reactive oxygen species, cellular stress, AAV serotypes, anticancer agents, transgene expression
- MeSH terms
- Arsenic Trioxide, Dependovirus, Animals, Antineoplastic Agents, Arsenicals, Cell Line, Humans, Oxides, Transduction, Genetic, Virion, Virus Replication
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.